Imidazopyridopyrimidine derivative compound and use thereof
申请人:HANMI PHARMACEUTICAL CO., LTD.
公开号:US10696675B2
公开(公告)日:2020-06-30
A novel imidazopyridine derivative compound and uses thereof are disclosed. An imidazopyridopyridine derivative compound of Chemical Formula 1 having selective inhibitory activity for a fibroblast growth factor receptor (FGFR) and a pharmaceutical composition including the compound are disclosed:
申请人:The Trustees of Columbia University in the City of
New York
公开号:EP2310401A1
公开(公告)日:2011-04-20
RNA-EDITING OLIGONUCLEOTIDES AND USES THEREOF
申请人:Korro Bio, Inc.
公开号:EP3914259A1
公开(公告)日:2021-12-01
Methods and Compositions for the ADAR-Mediated Editing of SERPINA1
申请人:Korro Bio, Inc.
公开号:US20210380980A1
公开(公告)日:2021-12-09
The present invention relates to methods and compositions for editing a SERPINA1 polynucleotide, e.g., a SERPINA1 polynucleotide comprising a SNP associated with alpha 1 antitrypsin deficiency. The invention also relates to methods and compositions for treating or preventing alpha 1 antitrypsin deficiency in a subject.